510(k) Report

510(k) · Cleared

Cleared

Cell-Dyn Emerald 22 System

K110381510(k) TraditionalCleared Dec 22, 2011315-day reviewClass II21 CFR 864.5220

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Laboratories · GKZ Counter, Differential Cell

Cleared on Dec 22, 2011 as substantially equivalent to K991605 (Abbott Laboratories, 1999) after a 315-day review. Its family tree reaches back 2 generations to 1997. 1 later device descends from it.

Decided
Dec 22, 2011
Review
315 days
Class
Class II
Product code
GKZ
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K971152 (1997). 1 later device descends from it, 1 citing it directly.

  1. Root · 2 generations backK971152 Abbott Cell-Dyn 4000 Immature Reticulocyte Fraction (Irf)Abbott Laboratories · 1997 · Recalled
  2. 1 generation backK991605 Cell-Dyn 3500 System with Immature Reticulocyte Fraction (Irf)…Abbott Laboratories · 1999 · Recalled
  3. This deviceK110381 Cell-Dyn Emerald 22 SystemAbbott Laboratories · 2011
  4. Descendant · cites it directly · 0 of its ownK190294 CELL-DYN Emerald 22 AL SystemAbbott Laboratories · 2019

Most influential descendants

Showing 1 of 1 · See all
  • K190294CELL-DYN Emerald 22 AL SystemAbbott Laboratories · 2019 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K971152Abbott Cell-Dyn 4000 Immature Reticulocyte Fraction (Irf)Abbott Laboratories19971
−1K991605Cell-Dyn 3500 System with Immature Reticulocyte Fraction (Irf), Cell-Dyn 3700…Abbott Laboratories19999
0 (this device)K110381Cell-Dyn Emerald 22 SystemAbbott Laboratories2011—
+1K190294CELL-DYN Emerald 22 AL SystemAbbott Laboratories2019—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201910
FIG. 1 — Lineage of K110381, 1997–2019Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GKZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GKZ device

  1. #1 K250943 Sysmex XR-Series (XR-10) Automated Hematology…score 13.2 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K991605Cell-Dyn 3500 System with Immature Reticulocyte Fraction (Irf), Cell-Dyn 3700 System…
Summary page 1
…on Name: Automated Differential Cell Counter (21 CFR 864.5220) Predicate Device: Abbott CELL-DYN 3700 System, K991605 Device Description: The CELL-DYN Emerald 22 System is a bench-top analyzer consisting of the main analyzer with data modu…
Abbott Laboratories19999

Also cleared against K991605: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K190294CELL-DYN Emerald 22 AL SystemAbbott Laboratories20190

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 14 years and passes through 1 company; a new generation was cleared every 12.5 years on median.
  • 2 of the 2 ancestors have a recall of any class.
  • Of its descendants, K190294 (Abbott Laboratories, 2019) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K991605.

How does its category compare?

All GKZ devices

GKZ Counter, Differential Cell: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · GKZ

4in 2025

2007: 62008: 62009: 62010: 42011: 32012: 32013: 12014: 32015: 32016: 32017: 42018: 32019: 52020: 12022: 32023: 42024: 32025: 42026 (partial year): 4
2007high 6 (2007) · low 0 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GKZ

108in 2025

2007: 117 days median2008: 99 days median2009: 147 days median2010: 290 days median2011: 315 days median2012: 408 days median2014: 165 days median2015: 273 days median2016: 198 days median2017: 280 days median2018: 270 days median2019: 210 days median2022: 638 days median2023: 329 days median2024: 157 days median2025: 108 days median2026 (partial year): 254 days median
2007high 638 (2022) · low 99 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GKZ

1in 2025

2007: 372008: 52009: 132010: 272011: 282012: 72013: 62015: 32016: 32017: 32018: 2, 2 Class I2019: 22020: 12022: 42023: 12025: 1
2007high 37 (2007) · low 0 (2014)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · GKZ

77in 2025

2007: 2682008: 9252009: 5592010: 8962011: 2,9052012: 2,9592013: 3,0702014: 3,1122015: 1,9722016: 3,3382017: 2292018: 4972019: 9082020: 3422021: 3912022: 1982023: 1552024: 1152025: 77
2007high 3,338 (2016) · low 77 (2025)2025

MAUDE reports naming product code GKZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007611737268
20086995925
2009614713559
2010429027896
20113315282,905
2012340872,959
20131—63,070
2014316503,112
2015327331,972
2016319833,338
201742803229
201832702 (2)497
201952102908
20201—1342
20210—0391
202236384198
202343291155
202431570115
20254108177
202642540—

What is it indicated for?

The CELL-DYN Emerald 22 System is a quantitative multi-parameter automated

hematology analyzer designed for in-vitro-diagnostic use in clinical laboratories for

enumeration of the following parameters: WBC, LYM%, LYM#, MON%, MON#,

NEU%, NEU#, EOS%, EOS# , BAS%, BAS#, RBC, HCT, MCV, RDW, HGB, MCH,

MCHC, PLT, MPV in K2 EDTA anti-coagulated whole blood.

The CELL-DYN Emerald 22 is indicated for use to identify patients with hematologic

parameters within and outside of established reference ranges.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K110381: Cell-Dyn Emerald 22 System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K110381

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026